Skip to main content

Table 3 Changes in the frequency of Pfdhfr and Pfdhps genotypes between 1998 and 2020

From: Drug resistance markers within an evolving efficacy of anti-malarial drugs in Cameroon: a systematic review and meta-analysis (1998–2020)

Gene

Mutation

Allele

1998–2008 (%, n/N)

2009–2020 (%, n/N)

P-value

Pfdhfr

N51I

N51

27.8 (765/2751)

33.1 (624/1887)

P < 0.0001*

51I

72.2 (1986/2751)

66.9 (1263/1887)

C59R

C59

23.5 (647/2751)

32.2 (621/1929)

P < 0.0001*

59R

76.5 (2104//2751)

67.8 (1308/1929)

S108N

S108

19.2 (569/2959)

32.4 (622/1921)

P < 0.0001*

108 N

80.8 (2390/2959)

67.6 (1299/1921)

Pfdhps

A437G

A437

69.6 (477/685)

53.1 (1004/1890)

P < 0.0001*

437G

30.4 (208/685)

46.9 (886/1890)

K540E

K540

100.0 (433/433)

99.6 (1849/1856)

P = 0.201

540E

0.0 (0/433)

0.4 (7/1856)

  1. *P < 0.05: Statistically significant, n: Number of amino acid substitutions, N: Total number of samples genotyped